Boranophosphate

First developed in the Shaw lab in 1990, boranophosphates have great potential as therapeutic and diagnostic agents, as the modification confers many unique properties.[1] The boranophosphate resembles the normal phosphate in that the negative charge is retained; however, the polarity of the molecule changes because the negative charge is localized on the remaining non-bridging oxygen.[2] Partitioning experiments have demonstrated that boranophosphates are more lipophilic than normal phosphates;[3] this could allow for increased cellular uptake and targeted delivery. In addition, boranophosphates have increased nuclease resistance without affecting activation of RNase H cleavage of RNA in RNA: boranophosphate hybrids.[3]

References

  1. ↑ Sood 1990
  2. ↑ He 1998
  3. 1 2 Shaw 2000
This article is issued from Wikipedia - version of the Sunday, June 14, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.